Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients.
Saved in:
| Title: | Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients. |
|---|---|
| Authors: | Poon, Victor1 (AUTHOR), Sutaria, Dhruvitkumar1 (AUTHOR), Prell, Rodney1 (AUTHOR), Halpern, Wendy1 (AUTHOR), Wong, Lisa1 (AUTHOR), Harris, Adam1 (AUTHOR), Wilkins, Justin2 (AUTHOR), Yoshida, Kenta1 (AUTHOR) yoshida.kenta@gene.com, Sane, Rucha1 (AUTHOR) sane.rucha@gene.com |
| Source: | CTS: Clinical & Translational Science. Jul2025, Vol. 18 Issue 7, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
